News

Weight loss simplified: Shed pounds with the affordable Ozempic alternative that doesn't require insurance (and that actually works)
SHOPPING: Give your weight loss efforts a serious push with Hims, the weight loss program that is tailored to your unique ...
Viking: I'm Bullish On Oral/Injectable GLP-1 Obesity Data Catalysts
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
University of Dundee1h
New spin-out targets obesity with muscle-sparing therapies
A University of Dundee spin-out has formed a new company dedicated to developing new obesity therapies that avoid the muscle ...
Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...
Dear Media on MSN30m
Exploring The Body Positivity-to-Ozempic Pipeline: How Did We Get Here? - Dear Media
Scroll back to the halcyon days of 2020, when the Internet was overflowing with self-love sermons, plus-size runway shows, and pastel infographics reminding us to “embrace every curve.” Now ...